A critical advance in cancer investigation is arising with the use of nanobodies to reactivate damaged p53. This vital malignant inhibitor protein is frequently disabled in many forms of tumors, resulting uncontrolled https://socialwebnotes.com/story7115603/vhh-fragments-revive-tumor-suppressor-p53-new-promising-approach-for-cancer-treatment